Letrozole (Synonyms: CGS 20267) |
| Catalog No.GC10726 |
Letrozole (CGS 20267) is an orally active nonsteroidal selective aromatase inhibitor with an IC50 of 11.5nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 112809-51-5
Sample solution is provided at 25 µL, 10mM.
Letrozole (CGS 20267) is an orally active nonsteroidal selective aromatase inhibitor with an IC50 of 11.5nM[1]. Letrozole prevents aromatase from producing estrogens by competitively and reversibly binding to the heme of its cytochrome P450 unit[2]. Letrozole is commonly used to treat certain types of breast cancer in postmenopausal women, including hormone receptor-positive breast cancer[3].
In vitro, Letrozole (100nM) treatment of breast cancer MCF7 cells for 72h significantly reduced the migration, invasion and adhesion of MCF7 cells when co-cultured with cancer-associated fibroblasts (CAFs), but had no effect on the proliferation of MCF7 cells[4]. Letrozole (10nM) treatment of breast cancer MCF7 cells for 24h and 48h significantly inhibited the levels of intracellular matrix metalloproteinases (MMPs) and also inhibited the stimulatory effect of testosterone on the proliferation of MCF7 cells[5].
In vivo, oral administration of Letrozole (1, 2.5mg/kg/day) to male Parkes mice for 28 days showed degenerative changes in the testicular histology of the mice, a significant decrease in the number of PCNA-positive germ cells in each seminiferous tubule in the testis, a significant increase in testosterone levels, but a significant decrease in estradiol levels[6]. Oral administration of Letrozole (0.5mg/kg/day) to rats with endometriosis for 3 weeks significantly reduced the size of the endometriosis, with a reduction percentage of 79.92% ± 7.89%[7].
References:
[1] Bhatnagar A S, Häusler A, Schieweck K, et al. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor[J]. The Journal of steroid biochemistry and molecular biology, 1990, 37(6): 1021-1027.
[2] Miller W R, Bartlett J, Brodie A M H, et al. Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?[J]. The oncologist, 2008, 13(8): 829-837.
[3] Barnadas A, Estévez L G, Lluch-Hernández A, et al. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer[J]. Advances in therapy, 2011, 28: 1045-1058.
[4] Li K, Kang H, Wang Y, et al. Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology[J]. Medical Oncology, 2016, 33: 1-11.
[5] Mitropoulou T N, Tzanakakis G N, Kletsas D, et al. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP‐2 and MMP‐9) by human epithelial breast cancer cells[J]. International journal of cancer, 2003, 104(2): 155-160.
[6] Verma R, Krishna A. Effect of Letrozole, a selective aromatase inhibitor, on testicular activities in adult mice: Both in vivo and in vitro study[J]. General and Comparative Endocrinology, 2017, 241: 57-68.
[7] Yarmolinskaya M, Molotkov A. Evaluation of the effectiveness of letrozole in the treatment of experimentally modeled endometriosis in rats[J]. Journal of Endometriosis and Pelvic Pain Disorders, 2019, 11(3): 126-131.
| Cell experiment [1]: | |
Cell lines | MCF7 cells |
Preparation Method | 4×105 carcinoma-associated fibroblasts (CAFs) were seeded on a 10cm culture dish. After co-culturing with 2×105 MCF7 cells using a standing transwell with or without 100nM Letrozole for 72h, the upper chamber was removed, and the chambers were fixed in 4% formaldehyde for 30min and stained with 5% crystal violet for 5min. The cells that migrated or invaded to the lower surface of the membrane were counted from 6 randomized fields at 100 times magnifications using an inverted microscope. The assay was performed in triplicate. |
Reaction Conditions | 100nM;72h |
Applications | In the presence of CAFs, Letrozole significantly reduced the migration, invasion, and adhesion of MCF7 cells, but had no effect on the proliferation of MCF7 cells. |
| Animal experiment [2]: | |
Animal models | Male Parkes strain mice |
Preparation Method | Mice were randomly divided into three groups (n=10 per group). The Group 1 was control and received the vehicle (1% aqueous solution of carboxmethylcellulose). The Group 2 and 3 were experimental received low dose (1mg/kg) and high dose (2.5mg/kg) of Letrozole through oral gavage, for 28 days. At the end of the experiment, animals were killed by decapitation under a mild dose of anesthetic ether and blood was collected. Serum was collected from blood and kept at 20℃ for further assay. Testis of one side of each animal was kept at 20℃ for immunoblot and the other side of the testis was fixed in Bouin’s fluid for immunohistochemistry. |
Dosage form | 1, 2.5mg/kg/day for 28 days; p.o. |
Applications | The testicular histology of mice treated with Letrozole showed degenerative changes, the number of PCNA-positive germ cells per seminiferous tubule in the testis decreased significantly, and the testosterone level increased significantly, but the estradiol level decreased significantly. |
References: [1]Li K, Kang H, Wang Y, et al. Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology[J]. Medical Oncology, 2016, 33: 1-11. [2]Verma R, Krishna A. Effect of Letrozole, a selective aromatase inhibitor, on testicular activities in adult mice: Both in vivo and in vitro study[J]. General and Comparative Endocrinology, 2017, 241: 57-68. | |
| Cas No. | 112809-51-5 | SDF | |
| Synonyms | CGS 20267 | ||
| Chemical Name | 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile | ||
| Canonical SMILES | C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3 | ||
| Formula | C17H11N5 | M.Wt | 285.3 |
| Solubility | ≥ 14.265mg/mL in DMSO | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.5051 mL | 17.5254 mL | 35.0508 mL |
| 5 mM | 0.701 mL | 3.5051 mL | 7.0102 mL |
| 10 mM | 0.3505 mL | 1.7525 mL | 3.5051 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *